Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.
Authors: Choi S; Asan Medical Center, Department of Clinical Pharmacology and Therapeutics, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Medical Center, Department of Medical Science and Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea., Seo J; Asan Medical Center, Department of Clinical Pharmacology and Therapeutics, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Medical Center, Department of Medical Science and Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea., Park S; Asan Medical Center, Department of Clinical Pharmacology and Therapeutics, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim NY; Hanmi Pharm. Co., Ltd., Seoul, Republic of Korea., Kim H; Hanmi Pharm. Co., Ltd., Seoul, Republic of Korea., Lim HS; Asan Medical Center, Department of Clinical Pharmacology and Therapeutics, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Medical Center, Department of Medical Science and Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Dec 01; Vol. 16, pp. 1715585. Date of Electronic Publication: 2025 Dec 01 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2025.1715585